7501 - 7550 of 9117 Results
Title
Year
- Detraining outcomes with expiratory muscle strength training in Parkinson disease2014RESTRICTEDTitle: Detraining outcomes with expiratory muscle strength training in Parkinson diseaseJournal Name: Journal of Rehabilitation Research and DevelopmentPublisher: Journal of Rehabilitation Research & DevelopmentVol: 51Issue #: 2Start Page: 305End Page: 310Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1682/jrrd.2013.05.0101Citation Count: 56
- The Unified Parkinson�s Disease Rating Scale as a predictor of peak aerobic capacity and ambulatory function2012RESTRICTEDTitle: The Unified Parkinson�s Disease Rating Scale as a predictor of peak aerobic capacity and ambulatory functionJournal Name: The Journal of Rehabilitation Research and DevelopmentPublisher: Journal of Rehabilitation Research & DevelopmentVol: 49Issue #: 8Start Page: 1269End Page: 1269Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1682/jrrd.2011.06.0103Citation Count: 28
-
OPENTitle: Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson’s Disease and Control SubjectsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 4Start Page: 761End Page: 770Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-160888Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5501392Citation Count: 97
-
OPENTitle: Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease GenesJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/835Best OA location URL: https://www.jove.com/pdf/835/application-c-elegans-dopamine-neuron-degeneration-assay-forCitation Count: 47
-
OPENTitle: Detection of Protein UbiquitinationJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 30Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/1293Best OA location URL: https://www.jove.com/pdf/1293/detection-of-protein-ubiquitinationCitation Count: 96
-
RESTRICTEDTitle: Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free AssaysJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 126Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3791/55361Best OA location URL: http://doi.org/10.3791/55361Citation Count: 7
-
RESTRICTEDTitle: Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the CommunityJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 73Issue #: 1Start Page: 85End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2015.3098Best OA location URL: http://doi.org/10.1001/jamaneurol.2015.3098Citation Count: 204
-
OPENTitle: Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive PhosphateJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 79Start Page: e50523End Page: e50523Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/50523Best OA location URL: https://www.jove.com/pdf/50523/metabolic-labeling-leucine-rich-repeat-kinases-1-2-with-radioactiveCitation Count: 5
- Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling2017RESTRICTEDTitle: Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and ModelingJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 123Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3791/55609Citation Count: 40
-
OPENTitle: Activation of recombinant NR1/NR2C NMDA receptorsJournal Name: The Journal of PhysiologyPublisher: WileyVol: 586Issue #: 18Start Page: 4425End Page: 4439Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1113/jphysiol.2008.158634Best OA location URL: http://doi.org/10.1113/jphysiol.2008.158634Citation Count: 106
-
RESTRICTEDTitle: Generation of Stable Transgenic C. elegans Using MicroinjectionJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 18Start Page: 16End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3791/833Best OA location URL: https://www.jove.com/pdf/833/generation-of-stable-transgenic-c-elegans-using-microinjectionCitation Count: 0
-
OPENTitle: Reliable Identification of Living Dopaminergic Neurons in Midbrain Cultures Using RNA Sequencing and TH-promoter-driven eGFP ExpressionJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 120Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/54981Best OA location URL: https://www.jove.com/pdf/54981/reliable-identification-living-dopaminergic-neurons-midbrain-culturesCitation Count: 9
- Dopamine Release at Individual Presynaptic Terminals Visualized with FFNs2009RESTRICTEDTitle: Dopamine Release at Individual Presynaptic Terminals Visualized with FFNsJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 30Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3791/1562Citation Count: 10
-
OPENTitle: Three-dimensional Tissue Engineered Aligned Astrocyte Networks to Recapitulate Developmental Mechanisms and Facilitate Nervous System RegenerationJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 131Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/55848Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5908484Citation Count: 19
-
OPENTitle: Clinical Correlations With Lewy Body Pathology inLRRK2-Related Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 72Issue #: 1Start Page: 100End Page: 100Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2014.2704Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/1934714/ncr140023.pdfCitation Count: 407
-
OPENTitle: Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 259Issue #: 9Start Page: 1840End Page: 1847Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-012-6419-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-012-6419-4.pdfCitation Count: 58
-
OPENTitle: Parkinsonism syndrome in heterozygotes for Niemann–Pick C1Journal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 335Issue #: 1-2Start Page: 219End Page: 220Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2013.08.033Best OA location URL: http://doi.org/10.1016/j.jns.2013.08.033Citation Count: 67
-
OPENTitle: Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 71Issue #: 2Start Page: 141End Page: 141Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2013.5528Best OA location URL: http://doi.org/10.1001/jamaneurol.2013.5528Citation Count: 239
-
OPENTitle: Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed inXenopus laevisoocytesJournal Name: The Journal of PhysiologyPublisher: WileyVol: 586Issue #: 1Start Page: 227End Page: 245Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1113/jphysiol.2007.143172Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2375544Citation Count: 99
-
OPENTitle: Reply to: “Cell Therapy for Huntington's Disease: Learning from Failure”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 788End Page: 789Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28500Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28500Citation Count: 1
-
OPENTitle: Non‐Motor Fluctuations in Parkinson's Disease: Validation of the Non‐Motor Fluctuation Assessment QuestionnaireJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1392End Page: 1400Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1002/mds.28507Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28507Citation Count: 47
- Mutation Screening of TFG in α‐Synucleinopathy and Amyotrophic Lateral Sclerosis2022RESTRICTEDTitle: Mutation Screening of TFG in α‐Synucleinopathy and Amyotrophic Lateral SclerosisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1756End Page: 1761Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29079Citation Count: 5
-
OPENTitle: Changes in Body Composition Before and After Parkinson's Disease DiagnosisJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1617End Page: 1623Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28536Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10775470/pdf/nihms-1945637.pdfCitation Count: 23
-
OPENTitle: A Novel SNCA A30G Mutation Causes Familial Parkinsonʼs DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1624End Page: 1633Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28534Best OA location URL: https://pub.dzne.de/record/155632Citation Count: 114
- Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment2021OPENTitle: Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression TreatmentJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2549End Page: 2558Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28548Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11822725Citation Count: 49
-
OPENTitle: Replication of a Novel Parkinson's Locus in a European Ancestry PopulationJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1689End Page: 1695Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28546Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28546Citation Count: 19
-
OPENTitle: Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA‐FLUO TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1704End Page: 1711Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28569Best OA location URL: https://hal.science/hal-03190779Citation Count: 25
- Phenoconversion from Possible REM Sleep Behavior to Parkinsonism in the Population‐Based CLSA2021RESTRICTEDTitle: Phenoconversion from Possible REM Sleep Behavior to Parkinsonism in the Population‐Based CLSAJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1466End Page: 1467Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28571Citation Count: 6
- Parkinson's Kinesia Paradoxa Is Not a Paradox2021OPENTitle: Parkinson's Kinesia Paradoxa Is Not a ParadoxJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1115End Page: 1118Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28550Citation Count: 34
-
OPENTitle: Scoring Algorithm‐Based Genomic Testing in Dystonia: A Prospective Validation StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1959End Page: 1964Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28614Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28614Citation Count: 27
- Reply to: “A New Approach to the Development of Disease‐Modifying Therapies for PD”2021RESTRICTEDTitle: Reply to: “A New Approach to the Development of Disease‐Modifying Therapies for PD”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1281End Page: 1282Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28588Citation Count: 0
- Cerebrospinal α‐Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort2021OPENTitle: Cerebrospinal α‐Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal CohortJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2048End Page: 2056Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28611Citation Count: 43
- A New Approach to the Development of Disease‐Modifying Therapies for PD2021RESTRICTEDTitle: A New Approach to the Development of Disease‐Modifying Therapies for PDJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1281End Page: 1281Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28589Citation Count: 1
- Beyond Just Connectivity — Neuronal Activity Drives α‐Synuclein Pathology2021RESTRICTEDTitle: Beyond Just Connectivity — Neuronal Activity Drives α‐Synuclein PathologyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1487End Page: 1488Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28618Citation Count: 6
-
OPENTitle: Intronic Haplotypes in GBA Modify Age at Diagnosis of Parkinson's: Replication in a SubgroupJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1468End Page: 1470Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28620Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28620Citation Count: 2
- Expectations of Benefit in a Trial of a Candidate Disease‐Modifying Treatment for Parkinson Disease2021RESTRICTEDTitle: Expectations of Benefit in a Trial of a Candidate Disease‐Modifying Treatment for Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1964End Page: 1967Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28630Citation Count: 6
- Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine Learning2021RESTRICTEDTitle: Detecting Sensitive Mobility Features for Parkinson's Disease Stages Via Machine LearningJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2144End Page: 2155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28631Citation Count: 89
- Comparing the Two Prodromal Parkinson's Disease Research Criteria—Lessons for Future Studies2021RESTRICTEDTitle: Comparing the Two Prodromal Parkinson's Disease Research Criteria—Lessons for Future StudiesJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1731End Page: 1732Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28637Citation Count: 8
- Reply to: “Increased alpha‐Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations”2021RESTRICTEDTitle: Reply to: “Increased alpha‐Synuclein Level in CD45+ Blood Cells in Asymptomatic Carriers of GBA Mutations”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1998End Page: 1999Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28678Citation Count: 0
- α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease2021OPENTitle: α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2508End Page: 2518Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28639Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28639Citation Count: 104
- Reply to: “Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?”2021RESTRICTEDTitle: Reply to: “Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1999End Page: 2000Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28697Citation Count: 0
-
OPENTitle: Multimodal Longitudinal Neurophysiological Investigations in Dopa‐Responsive DystoniaJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1986End Page: 1987Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28679Best OA location URL: https://doi.org/10.1002/mds.28679Citation Count: 6
- MicroRNAs as Molecular Biomarkers for Parkinson's Disease Progression2021RESTRICTEDTitle: MicroRNAs as Molecular Biomarkers for Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1793End Page: 1793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28700Citation Count: 1
- CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB2021OPENTitle: CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLBJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2595End Page: 2604Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28704Best OA location URL: https://pub.dzne.de/record/163488Citation Count: 29
- Exposure to Phosphoglycerate Kinase 1 Activators and Incidence of Parkinson's Disease2021RESTRICTEDTitle: Exposure to Phosphoglycerate Kinase 1 Activators and Incidence of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2419End Page: 2425Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28712Citation Count: 24
- A Role of Aging in the Progression of Cortical Excitability in Benign Adult Familial Myoclonus Epilepsy type 1 Patients2021RESTRICTEDTitle: A Role of Aging in the Progression of Cortical Excitability in Benign Adult Familial Myoclonus Epilepsy type 1 PatientsJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2446End Page: 2448Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28718Citation Count: 8
- Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric Signs2021RESTRICTEDTitle: Serotonergic and Dopaminergic Lesions Underlying Parkinsonian Neuropsychiatric SignsJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2888End Page: 2900Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28722Citation Count: 80
-
OPENTitle: Systematic Assessment of 10 Biomarker Candidates Focusing on α‐Synuclein‐Related DisordersJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2874End Page: 2887Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28738Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28738Citation Count: 116
-
OPENTitle: Polyglutamine‐Expanded Ataxin‐3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral BloodJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2675End Page: 2681Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.28749Best OA location URL: https://doi.org/10.1002/mds.28749Citation Count: 35
- Reply to: “Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy”2021RESTRICTEDTitle: Reply to: “Experience with a New Index to Differentiate Parkinson's Disease and Progressive Supranuclear Palsy”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2208End Page: 2209Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28725Citation Count: 0